An analysis from the Phase 3 CheckMate 77T trial confirms that perioperative nivolumab does not compromise health-related quality of life (HRQoL) in patients with resectable non-small cell lung cancer ...

A new analysis from the COMPEL trial shows that patients with EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC) who experienced non-central nervous system (CNS) progression on ...

A new study presented at the International Association for the Study of Lung Cancer 2025 World Conference on Lung Cancer (WCLC) validates the use of Sybil, a deep learning artificial intelligence ...

A combination of iza-bren (BL-B01D1), a novel bispecific antibody-drug conjugate (ADC), with osimertinib demonstrated a 100% objective response rate (ORR) in patients with first-line EGFR-mutated ...

A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrated encouraging safety and efficacy results in previously treated patients with EGFR-mutated non-small cell lung cancer (NSCLC), ...

Results from the FigHTN Phase 2 clinical trial showed baxdrostat, a new medication that inhibits the production of the hormone aldosterone, lowered systolic blood pressure by about 5% when added to ...

University of Leicester scientists have identified two extraordinary new fossils - tiny prehistoric flying reptiles, ...

Trial suggests using bedside scans instead of traditional stethoscopes shortens hospitalization and lowers costs.

A new study from the University of North Carolina at Chapel Hill shows that insect populations are rapidly declining even in relatively undisturbed landscapes, raising concerns about the health of ...

A study has found that adolescents become highly motivated to seek rewards after just a few hours of social isolation. This ...

The most common and aggressive type of adult brain cancer, glioblastoma multiforme (GBM) is notoriously resistant to ...

A long-term study spanning more than 50 years illustrates how the beavers that have returned to the Evo region in southern ...